FDA Warns Stryker Again Over Quality Control
By Amanda Ernst · May 5, 2008, 12:00 AM EDT
Stryker Corp. has come under fire from the U.S. Food and Drug Administration again, three months after it pulled a number of its popular Trident hip replacement components off the market...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login